The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for δ/μ opioid receptor agonists and neurokinin 1 receptor antagonists

Takashi Yamamoto, Padma Nair, Neil E. Jacobsen, Peg Davis, Shou Wu Ma, Edita Navratilova, Sharif Moye, Josephine Lai, Henry I. Yamamura, Todd W. Vanderah, Frank Porreca, Victor J Hruby

Research output: Contribution to journalArticlepeer-review

36 Scopus citations

Abstract

To provide new insight into the determining factors of membrane-bound peptide conformation that might play an important role in peptide-receptor docking and further biological behaviors, the dodecylphosphocholine (DPC) micelle-bound conformations of bifunctional peptide derivatives of δ-preferring opioid agonists, and NK1 antagonists (1: Tyr-D-Ala-Gly-Phe- Met-Pro-Leu-Trp-O-3,5-Bzl(CF3)2; 2: Tyr-D-Ala-Gly-Phe-Met- Pro-Leu-Trp-NH-3,5-Bzl(CF3)2; 3: Tyr-D-Ala-Gly-Phe-Met- Pro-Leu-Trp-NH-Bzl) were determined based on 2D NMR studies. Although the differences in the primary sequence were limited to the C-terminus, the obtained NMR conformations were unexpectedly different for each compound. Moreover, their biological activities showed different trends in direct relation to the compound-specific conformations in DPC micelles. The important result is that not only were the NK1 antagonist activities different (the pharmacophore located at the C-terminus)but the opioid agonist activities (this pharmacophore was at the structurally preserved N-terminus) also were shifted, suggesting that a general conformational change in the bioactive state was induced due to relatively small and limited structural modifications.

Original languageEnglish (US)
Pages (from-to)6334-6347
Number of pages14
JournalJournal of Medicinal Chemistry
Volume51
Issue number20
DOIs
StatePublished - Oct 23 2008

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Fingerprint

Dive into the research topics of 'The importance of micelle-bound states for the bioactivities of bifunctional peptide derivatives for δ/μ opioid receptor agonists and neurokinin 1 receptor antagonists'. Together they form a unique fingerprint.

Cite this